Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia
NCT07701759
·
clinicaltrials.gov ↗
RECRUITING
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
ranibizumab
Sponsor
Minia University